Recent studies in our laboratory reported frequent loss of heterozygosity (LOH) on mouse chromosome 4 in T-cell lymphomas, identifying three candidate tumor suppressor regions (TLSR1 ± 3). To determine the possible existence of other tumor suppressor gene loci on the proximal-mid part of chromosome 4 and to clarify whether the p16
Recent studies in our laboratory reported frequent loss of heterozygosity (LOH) on mouse chromosome 4 in T-cell lymphomas, identifying three candidate tumor suppressor regions (TLSR1 ± 3). To determine the possible existence of other tumor suppressor gene loci on the proximal-mid part of chromosome 4 and to clarify whether the p16
INK4a
(a and b) and p15
INK4b genes are the inactivation targets of deletion at TLSR1, we have tested 73 g-radiationinduced T-cell lymphomas of F1 hybrid mice by LOH analysis. Frequent LOH was found at the INK4a and INK4b loci and the surrounding markers D4Mit77, D4Mit245 and D4Wsm1. In addition, we identi®ed two distinct regions of signi®cant allelic losses in the proximal-mid part of chromosome 4, de®ned by the markers D4Mit116 (TLSR4) and D4Mit21 (TLSR5). Taken together, this evidence and our previous data indicate the existence of at least ®ve dierent candidate sites for tumor suppressor genes on chromosome 4, thus revealing a main role for this chromosome in the development of mouse T-cell lymphomas.
Keywords: mouse T-cell lymphomas; g-irradiation; LOH; proximal-mid chromosome 4; tumor suppressor loci Frequent allelic losses associated with particular cancers may indicate the sites of tumor suppressor genes. Such a pattern has been observed on mouse chromosome 4 in dierent types of primary tumors, including lung cancers induced by vinyl carbamate (Herzog et al., 1994 (Herzog et al., , 1995 or by 4-methylnitrosamino-1-3-pyridyl-1-butanone (Hegi et al., 1994) , 2',3'-dideoxycytidine-and 1,3-butadiene-induced primary lymphomas (Zhuang et al., 1996) , and mammary tumors induced by medroxyprogesterone acetate and 7,12-dimethylbenzoanthracene (Aldaz et al., 1996) . In addition, primary tumors arising in mice transgenic for the mammary tumor virus /v-Ha-ras (Radany et al., 1997) and for the neu proto-oncogene (Ritland et al., 1997) , as well as in cell lines derived from hepatocarcinomas (Lee et al., 1995; Miyasaka et al., 1995) , also revealed frequent loss of heterozygosity (LOH) on mouse chromosome 4. Recent studies in our laboratory reported a high frequency of allelic losses on this chromosome in g-radiation-induced T-cell lymphomas of F1 hybrid mice (Santos et al., 1996 (Santos et al., , 1998 . Speci®cally, LOH was observed between D4Wsm1 (an internal marker of the interferon alpha gene, Ifa) and D4Mit9, de®ning a minimal region of LOH named TLSR1 (Thymic lymphoma Suppressor region 1) (Santos et al., 1996) . In addition, we identi®ed two distinct regions in the distal part of chromosome 4, one located around D4Mit205b (TLSR2), and the other mapped within the interval de®ned by Mom-1 and D4Mit68 (TLSR3) (Santos et al., 1998) .
In another paper we examined the molecular status of the mouse p16
INK4a and p15
INK4b genes in T-cell lymphomas induced by g-rays (Malumbres et al., 1997) , since (i) they were mapped to the cytogenetic position C3-C6 on chromosome 4 (Quelle et al., 1995) , an interval which included TLSR1; and (ii) human p16
and p15
INK4b genes are known to be inactivated in many tumor types (Kamb et al., 1994; Nobori et al., 1994; Herman et al., 1996) . In the study mentioned, we showed that although homozygous deletions and point mutations were not very frequent, p15
INK4b and, to less extend p16
INK4a , were found frequently hypermethylated and inactivated at the transcriptional level (Malumbres et al., 1997) . We also found a high concordance between samples with LOH at the p15
INK4b gene and samples with LOH on chromosome 4 in TLSR1. However, two tumors exhibiting LOH at p15 INK4b failed to detect allelic losses at D4Wsm1 and D4Mit9 (Malumbres et al., 1997) , suggesting that p15
INK4b is not the only candidate tumor suppressor gene for TLSR1.
It is noteworthy that the proximal-mid part of mouse chromosome 4 contains the syntenic counterparts of human genomic regions 6q14 ± 21, 9p21 ± 23 and 9q22 ± 34 (Mock and Hirano, 1998) (see also Figure 1 ) that are frequently deleted in a wide variety of cancers (Bell et al., 1997; Cairns et al., 1997; Simoneau et al., 1996 Simoneau et al., , 1999 . In this context, we have carried out a wide screen for allelic losses on the proximal-mid part of chromosome 4 in g-radiationinduced T-cell lymphomas of F1 hybrid mice to determine the potential existence of new tumor suppressor gene loci and to clarify whether TLSR1 is the domain of p16
INK4a and/or p15 INK4b . DNAs from 73 T-cell lymphomas induced by g-rays in (C57BL/6J x BALB/cJ) F1 mice (47 tumors) and the reciprocal strain (BALB/cJ x C57BL/6J) F1 (26 tumors) were screened for LOH on the proximal-mid part of chromosome 4 with 13 microsatellite markers (D4Mit1, D4Mit21, D4Mit151, D4Mit114, D4Mit116, D4Mit152, D4Mit77, D4Mit245, D4Wsm1, D4Mit185, D4Mit9, D4Mit166 and D4Mit37). Polymorphisms for exons 1a (Malumbres et al., 1997) and 1b (Herzog and You, 1997) of the p16
INK4a locus, and for an AC-repeat adjacent to p15
INK4b (Malumbres et al., 1998a) , were also analysed in this survey. We found that 29 of 73 (39.7%) tumors exhibited allelic losses in at least one of the analysed polymorphic markers. To determine the signi®cance of allelic losses, we genotyped the Tcell lymphomas with six polymorphic microsatellites located on chromosomes 1 (Crp), 7 (Hbb), 11 (Atp1b2), 13 (D13Mit36) 16 (D16Mit122), and 17 (D17Mit20). All tumors analysed retained heterozygosity for markers located on chromosomes 7, 13, and 17. Losses of heterozygosity were infrequently detected at Crp (1/73), Atp1b2 (1/73), and D16Mit122 (4/73). Comparative analyses between LOH occurring on each chromosome 4 marker and those appearing on the other six chromosomes were performed by w T-cell lymphomas with signi®cant allele losses on chromosome 4 (29 tumors) were classi®ed in 12 dierent patterns of LOH (types I ± XII) (Figure 1) . Fourteen of these tumors showed local patterns of allele loss (types V ± XII). Of these, ®ve tumors displayed LOH exclusively at D4Mit116 (type IX) whereas two tumors exhibited allele loss exclusively at D4Mit21 (type XI). Interestingly, there were three lymphomas that harbored LOH at p16
INK4a (a and b) and p15
INK4b loci, but dier each other in the pattern of LOH at surrounding markers: D4Mit77/D4Mit245 (two tumors, type VII) or D4Wsm1 (one tumor, type VIII). These data are consistent with the existence of three dierent non-contiguous areas of allele loss de®ned by the INK4 loci, D4Mit116 and D4Mit21, respectively. To establish whether homozygous deletions (HD) occurred at markers located between these areas in the tumors with local LOH patterns, we performed comparative multiplex PCR ampli®cations using the microsatellite marker Atp1b2 (Santos et al., 1995) as a control. The co-ampli®cation of control and loci of interest allowed us to rule out the occurrence of homozygous deletions. Figure 1 A loss of heterozygosity (LOH) study with 16 polymorphic markers in g-radiation-induced T-cell lymphomas de®nes two novel candidate Thymic Lymphoma Suppressor Region (TLSR4 and TLSR5) at the proximal-mid part of mouse chromosome 4. This analysis also suggests that TLSR1 seems to be the site where the INK4a and INK4b loci reside. Allele typings and scoring of LOH were performed as described (Santos et al., 1996) . Microsatellite markers were ampli®ed using PCR primers obtained from the Mouse Genome Database (http://www.informatics.jax.org). PCR/SSCP analyses for the detection of allelic losses within exon 1a of p16
INK4a were conducted using the primers and conditions described previously (Malumbres et al., 1997) . Exon 1b of the p16 . Thirty cycles of ampli®cation were carried out as follows: 958C for 30 s, 608C for 30 s, and 728C for 1 min. After ampli®cation PCR products were digested with BamHI at 378C overnight, because the polymorphic site is a BamHI target for the nucleotide sequence corresponding to BALB/cJ DNA. PCR-restriction length fragments were electrophoresed in 6% denaturing acrylamide TBE-buered gels, and then silver stained using conventional silver staining. Primer sequences and conditions for ampli®cation of the AC-repeat adjacent to p15 INK4b were described in Malumbres et al. (1998a) . Genetic markers are positioned according to the genetic linkage map data obtained from the Mouse Genome Database. T-cell lymphomas with allelic losses are classi®ed into 12 patterns of LOH (I ± XII). The number of tumors for each type are given in parenthesis. White boxes indicate the presence of the two alleles and black boxes correspond to loss of heterozygosity. Words in black boxes denote the lost alleles: BAL, BALB/cJ; B6, C57BL/6J; ++homozygous deletion. Left bars depict human syntenic correspondence of mouse chromosome 4 regions. Right bars denote the Thymic Lymphoma Suppressor Regions TLSR1 ± 5. * LOH data published in a previous paper (Santos et al., 1998) Loss of heterozygosity on chromosome 4 in T-cell lymphomas B Mele Â ndez et al Tumors with LOH patterns corresponding to types VII and VIII (Figure 1) (Gupta et al., 1997) . If we assume that the INK4 loci is distal to D4Wsm1, ®ve interstitial deletions or four somatic recombination events should be produced to explain the complex LOH pattern found in this tumor. If we now place the INK4 loci proximal to D4Wsm1, the occurrence of six interstitial deletions or ®ve somatic recombination events would be needed to explain the pattern of allelic losses. According to this, we conclude that the INK4 loci should be located distal to D4Wms1 rather than proximal, as proposed by Zhang et al. (1998) . This interpretation is reinforced by the fact that the p16
INK4a locus is a hot spot of recombination in human T-cell acute lymphoblastic leukemias (Cayuela et al., 1997; Gardie et al., 1998) . Finally, the high signi®cance of the allelic losses found at the INK4 loci (w 2 =87.77, d.f.=1, P50.0000001) together with the involvement of p16
INK4a and, mainly p15
INK4b
, in murine T-cell lymphomagenesis (Malumbres et al., 1997 (Malumbres et al., , 1998b , strongly support the notion that these genes are the candidates for TLSRI.
In addition, our data clearly suggest the existence of a distinct minimal region of LOH centered at D4Mit116, which showed the highest signi®cance of allelic losses found in this survey on chromosome 4 (w 2 =106.16, d.f.=1, P50.0000001). This fact together with the existence of tumors with LOH occurring exclusively at this marker, suggest that a new thymic lymphoma suppressor region (TLSR4) exist in the proximal-mid part of chromosome 4. This observation contrasts with data reported by other authors in tumorigenic mouse lung epithelial cells (Herzog et al., 1996) , since they demonstrated frequent allelic losses at p16
, but failed to detect LOH at D4Mit116. On the other hand, TLSR4 might be syntenic to the human region 9p22 ± 23 . Several studies in human tumors have provided wide evidence of a region of LOH on 9p22 ± 23 involving markers outside of INK4a and INK4b loci (Farrell et al., 1997; Holland et al., 1994; Kim et al., 1997; Neville et al., 1995; Waber et al., 1997) . Thus, we think that is highly probable that a putative tumor suppressor gene other than p16
INK4b exist at TLSR4, which is also involved in the development of g-radiation-induced T-cell lymphomas.
Finally, this analysis also served to demonstrate a new area of non-contiguous allele loss encompassing the D4Mit21 (w 2 =52.77, d.f.=1, P50.0000001). This w 2 value is clearly signi®cant but lower than those found for D4Mit116 and the INK4 loci. To reinforce the signi®cance of the allelic losses at D4Mit21, we carried out an additional allelotype analysis in 49 gradiation-T-cell lymphomas of (C57BL/6J x RF/J) F1 hybrid mice. We detected LOH in 10 of 49 (20.4%) tumors analysed. When we considered LOH occurring at D4Mit21 in all the analysed lymphomas, the w 2 values were considerably increased (w 2 =79.27, d.f.=1, P50.0000001). These results and the existence of tumors with LOH occurring exclusively at D4Mit21, clearly suggest that another dierent thymic lymphoma suppressor region (TLSR5) may be de®ned on the proximal-mid part of chromosome 4. Interestingly, the D4Mit21 marker lies within the interval de®ned by D4Mit4 (12.1 cM) and D4Mit217 (28.6 cM), where Tgfbr1 (type I receptor for TGF-b) gene was mapped (Kuan and Kono, 1998) , and TGF-b can induce the transcriptional activation of p15 INK4b (Hannon and Beach, 1994) . The orthologous human type I receptor for TGF-b (TGFBR1) was initially mapped to the chromosome band 9q33 ± 34 (Johnson et al., 1995) , where frequent allelic losses were found in several types of tumors (Miura et al., 1995; Schultz et al., 1995; Simoneau et al., 1996; Takita et al., 1997) . However, a recent report has presented evidence for 9q22 as the new map position of TGFBR1 (Pasche et al., 1998) . Interestingly, the genes responsible for the naevoid basal cell carcinoma syndrome (NBCCS) and the multiple self-healing squamous epithelioma (MSSE), proposed to be putative tumor suppressor genes, were mapped on 9q22 (Shanley et al., 1995; Holmberg et al., 1996; Richards et al., 1997) . In addition, evidence for a novel candidate tumor suppressor gene region at 9q22.3 has been recently reported in bladder cancer (Simoneau et al., 1999) . All this evidence supports the notion that Tgfbr1 is a good candidate tumor suppressor gene for TLSR5. To determine the possible involvement of this gene in T-cell lymphomagenesis, we intended to perform a LOH analysis using a PCR-RL polymorphism described by Kuan and Kono (1998) . Unfortunately, this marker was not informative in our F1 hybrid mice.
In summary, the accumulation of ®ve candidate sites for potential tumor suppressor genes in mouse chromosome 4 clearly indicates that this chromosome may play an important role in the development of mouse tumors. This situation clearly contrasts to that observed in humans, where the orthologous sites are distributed along several distinct chromosomes. If such loci are essential in the control of progression through the cell cycle, it is conceivable to speculate that the distribution of the putative tumor suppressor genes might be more advantageous in mouse than in human in terms of adaptive value.
